BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18000812)

  • 1. Spontaneous crystallinity loss of drugs in the disordered regions of poly(ethylene oxide) in the presence of water.
    Marsac PJ; Romary DP; Shamblin SL; Baird JA; Taylor LS
    J Pharm Sci; 2008 Aug; 97(8):3182-94. PubMed ID: 18000812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
    Abu-Diak OA; Jones DS; Andrews GP
    J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the aqueous dissolution of semicrystalline poly(ethylene oxide) using infrared chemical imaging: the effects of molecular weight and crystallinity.
    Coutts-Lendon C; Koenig JL
    Appl Spectrosc; 2005 Aug; 59(8):976-85. PubMed ID: 16105205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of acetaminophen's solubility in poly(ethylene oxide) at room temperature using the Flory-Huggins theory.
    Yang M; Wang P; Gogos C
    Drug Dev Ind Pharm; 2013 Jan; 39(1):102-8. PubMed ID: 22356356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of molecular weight, temperature, and additives on the moisture sorption properties of polyethylene glycol.
    Baird JA; Olayo-Valles R; Rinaldi C; Taylor LS
    J Pharm Sci; 2010 Jan; 99(1):154-68. PubMed ID: 19655373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid state NMR perspective of drug-polymer solid solutions: a model system based on poly(ethylene oxide).
    Schachter DM; Xiong J; Tirol GC
    Int J Pharm; 2004 Aug; 281(1-2):89-101. PubMed ID: 15288346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer-mediated disruption of drug crystallinity.
    Rawlinson CF; Williams AC; Timmins P; Grimsey I
    Int J Pharm; 2007 May; 336(1):42-8. PubMed ID: 17157459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of physical properties of injection molded systems based on poly(ethylene oxide) (PEO).
    Pajander J; Rensonnet A; Hietala S; Rantanen J; Baldursdottir S
    Int J Pharm; 2017 Feb; 518(1-2):203-212. PubMed ID: 28025074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms by which moisture generates cocrystals.
    Jayasankar A; Good DJ; Rodríguez-Hornedo N
    Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular-Level Control of Ciclopirox Olamine Release from Poly(ethylene oxide)-Based Mucoadhesive Buccal Films: Exploration of Structure-Property Relationships with Solid-State NMR.
    Urbanova M; Gajdosova M; Steinhart M; Vetchy D; Brus J
    Mol Pharm; 2016 May; 13(5):1551-63. PubMed ID: 27019088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New technology for the investigation of water vapor sorption-induced crystallographic form transformations of chemical compounds: a water vapor sorption gravimetry-dispersive Raman spectroscopy coupling.
    Feth MP; Jurascheck J; Spitzenberg M; Dillenz J; Bertele G; Stark H
    J Pharm Sci; 2011 Mar; 100(3):1080-92. PubMed ID: 20740677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTIR spectroscopic study of poly(ethylene glycol)-nifedipine dispersion stability in different relative humidities.
    Iqbal WS; Chan KL
    J Pharm Sci; 2015 Jan; 104(1):280-4. PubMed ID: 25410816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films.
    Prodduturi S; Manek RV; Kolling WM; Stodghill SP; Repka MA
    J Pharm Sci; 2005 Oct; 94(10):2232-45. PubMed ID: 16136579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deliquescence of pharmaceutical systems.
    Mauer LJ; Taylor LS
    Pharm Dev Technol; 2010 Dec; 15(6):582-94. PubMed ID: 19895256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of poly(ethylene oxide) as a drug carrier in hot-melt extrusion.
    Li L; AbuBaker O; Shao ZJ
    Drug Dev Ind Pharm; 2006 Sep; 32(8):991-1002. PubMed ID: 16954112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.